Fachrepositorium Lebenswissenschaften

71 Treffer

Seiten

Suche

Publisso-Menue

Seiten

Empowering therapeutic antibodies with IFN-α for cancer immunotherapy

2019 . Guo, Jun | Xiao, Yu | Iyer, Ramesh | Lu, Xin | Lake, Marc | Ladror, Uri | Harlan, John | Samanta, Tanushree | Tomlinson, Medha | Bukofzer, Gail | Donawho, Cherrie | Shoemaker, Alex | Huang, Tzu-Hsuan

State of PD-L1 and PD-1 screening and therapy in NSCLC

2018 . Bruehl, Frido | Csanádi, Ágnes | Neeff, Hannes | Rawluk, Justyna | Kayser, Gian

Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection

T cell mediated immunity after combination therapy with intralesional PV-10 and blockade of the PD-1/PD-L1 pathway in a murine melanoma model

2018 . Liu, Hao | Weber, Amy | Morse, Jennifer | Kodumudi, Krithika | Scott, Ellen | Mullinax, John | Sarnaik, Amod A. | Pilon-Thomas, Shari

Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma

2017 . Takahashi, Yutaka | Yasui, Tomohiro | Tamari, Keisuke | Minami, Kazumasa | Otani, Keisuke | Isohashi, Fumiaki | Seo, Yuji | Kambe, Ryosuke | Koizumi, Masahiko | Ogawa, Kazuhiko

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma

Cross-Fertilization between Computational Morphogenesis and Digital Pathology

2016 . Siregar, P. | Julen, N.

Pembrolizumab (Keytruda) - Kopf-Hals-Bereich, Plattenepithelkarzinom > Plattenepithelkarzinom > nach platinbasierter Chemotherapie, PD-L1 >50%

Stand: 08/2019 . Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie

Pembrolizumab (Keytruda) - Lungenkarzinom, nicht-kleinzellig (NSCLC) > Erstlinie

Stand: Mai 2018 . Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie

Atezolizumab (neues Anwendungsgebiet, NSCLC, hohe PD-L1 Expression)

Seiten